.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Johnson and Johnson
Daiichi Sankyo
Covington
Chinese Patent Office
Teva
Argus Health
Accenture
UBS
Cantor Fitzgerald

Generated: June 23, 2017

DrugPatentWatch Database Preview

Diatrizoate sodium - Generic Drug Details

« Back to Dashboard

What are the generic sources for diatrizoate sodium and what is the scope of diatrizoate sodium patent protection?

Diatrizoate sodium
is the generic ingredient in four branded drugs marketed by Bayer Hlthcare, Ge Healthcare, and Mallinckrodt, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for diatrizoate sodium.

Summary for Generic Name: diatrizoate sodium

Tradenames:4
Patents:1
Applicants:3
NDAs:4
Drug Master File Entries: see list9
Bulk Api Vendors: see list30
Clinical Trials: see list2,346
Patent Applications: see list4,689
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diatrizoate sodium at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ge Healthcare
HYPAQUE SODIUM 20%
diatrizoate sodium
SOLUTION;URETERAL009561-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Bayer Hlthcare
UROVIST SODIUM 300
diatrizoate sodium
INJECTABLE;INJECTION087725-001Sep 23, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE
diatrizoate sodium
FOR SOLUTION;ORAL, RECTAL011386-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE
diatrizoate sodium
INJECTABLE;INJECTION009561-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ge Healthcare
HYPAQUE
diatrizoate sodium
SOLUTION;ORAL, RECTAL011386-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Farmers Insurance
Dow
QuintilesIMS
AstraZeneca
Chubb
Covington
Healthtrust
Cerilliant
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot